skip to main content

S. 3077 (114th): MEDS Act


We don’t have a summary available yet.

The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress, and was published on Jun 20, 2016.


Marijuana Effective Drug Studies Act of 2016 or the MEDS Act

This bill amends the Controlled Substances Act to:

establish, with respect to marijuana research, a new federal registration process that is separate from the process for research involving other schedule I drugs; establish a process for registering persons to manufacture or distribute marijuana for purposes of either research or the commercial production of certain approved drugs containing or derived from marijuana; and modify other requirements related to marijuana research and production.